A detailed history of Signaturefd, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Signaturefd, LLC holds 1,353 shares of ALKS stock, worth $37,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,353
Previous 1,417 4.52%
Holding current value
$37,478
Previous $34,000 8.82%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$23.01 - $28.55 $1,472 - $1,827
-64 Reduced 4.52%
1,353 $37,000
Q2 2024

Jul 29, 2024

BUY
$23.21 - $27.24 $11,140 - $13,075
480 Added 51.23%
1,417 $34,000
Q1 2024

May 03, 2024

BUY
$26.4 - $32.56 $3,775 - $4,656
143 Added 18.01%
937 $25,000
Q4 2023

Jan 31, 2024

BUY
$23.37 - $28.68 $10,236 - $12,561
438 Added 123.03%
794 $22,000
Q3 2023

Nov 03, 2023

SELL
$27.17 - $31.97 $13,530 - $15,921
-498 Reduced 58.31%
356 $9,000
Q2 2023

Aug 01, 2023

BUY
$28.34 - $33.63 $13,263 - $15,738
468 Added 121.24%
854 $26,000
Q1 2023

Apr 28, 2023

BUY
$25.31 - $29.02 $4,100 - $4,701
162 Added 72.32%
386 $10,000
Q4 2022

Jan 27, 2023

BUY
$21.94 - $26.24 $2,215 - $2,650
101 Added 82.11%
224 $5,000
Q3 2022

Nov 08, 2022

BUY
$22.0 - $31.87 $1,584 - $2,294
72 Added 141.18%
123 $3,000
Q2 2022

Aug 10, 2022

SELL
$26.4 - $30.54 $1,240 - $1,435
-47 Reduced 47.96%
51 $2,000
Q1 2022

May 02, 2022

BUY
$23.07 - $27.99 $645 - $783
28 Added 40.0%
98 $3,000
Q4 2021

Jan 25, 2022

SELL
$21.47 - $32.08 $300 - $449
-14 Reduced 16.67%
70 $2,000
Q3 2021

Oct 28, 2021

BUY
$23.37 - $32.13 $327 - $449
14 Added 20.0%
84 $3,000
Q2 2021

Jul 26, 2021

SELL
$18.78 - $25.15 $525 - $704
-28 Reduced 28.57%
70 $2,000
Q1 2021

Apr 30, 2021

BUY
$18.21 - $23.2 $1,784 - $2,273
98 New
98 $2,000
Q2 2020

Jul 30, 2020

SELL
$13.31 - $19.41 $2,395 - $3,493
-180 Closed
0 $0
Q1 2020

Apr 23, 2020

BUY
$13.06 - $21.24 $1,671 - $2,718
128 Added 246.15%
180 $3,000
Q4 2019

Feb 05, 2020

BUY
$17.29 - $21.74 $899 - $1,130
52 New
52 $1,000
Q2 2019

Jul 31, 2019

SELL
$21.47 - $37.33 $2,147 - $3,733
-100 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$28.4 - $36.49 $994 - $1,277
-35 Reduced 25.93%
100 $4,000
Q4 2018

Feb 13, 2019

BUY
$27.94 - $44.61 $2,794 - $4,461
100 Added 285.71%
135 $4,000
Q1 2018

May 08, 2018

BUY
$53.61 - $67.26 $1,876 - $2,354
35 New
35 $2,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.55B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.